Chun-Xia Li1, Christa Payne2, Xiaoping Hu3, Jocelyne Bachevalier2,4, and Xiaodong Zhang1,4
1Yerkes Imaging Center, Yerkes National Primate Research Center, Emory University, Atlanta, GA, United States, 2Department of Psychology and Yerkes National Primate Research Center, Emory University, Atlanta, GA, United States, 3Department of Bioengineering, University of California, Riverside, CA, United States, 4Division of Neuropharmacology and Neurologic Disease, Yerkes National Primate Research Center, Emory University, Atlanta, GA, United States
Synopsis
In the present study, in
vivo MR spectroscopy was employed to investigate the neuro-metabolites
changes of dorsolateral prefrontal cortex (DLPFC) and
ventrolateral prefrontal cortex (VLPFC) in adult macaques with neonatal
hippocampus lesion (Neo-H). Significant
metabolite changes were seen in the right DLPFC of
the Neo-H monkeys but not in the VLPFC, and significantly correlated
with the working memory scores. Also, lateralization of the cerebral metabolite
changes was observed. The results suggest that the neuro-metabolites changes in
DLPFC and VLPFC of adult monkeys resulted from early insult to the hippocampus
and the effect is mainly seen in the right hemisphere.
Introduction
Impaired memory is an important
component of many developmental neuropsychiatric disorders in humans, such as
schizophrenia (SZ), autism and stress disorders, that are often associated with
medial temporal lobe dysfunction. Neonatal hippocampal
(Neo-H) lesions in animals induce postpubertally manifested changes
in prefrontal cortex (PFC) mimicking most
aspects of SZ and has become the popular
animal models in SZ researches [1-2]. Adult
monkeys with Neo-H lesions have impaired working
memory processes mediated by dorsolateral prefrontal cortex (DLPFC) but not by ventrolateral prefrontal cortex (VLPFC) [3]. Proton Magnetic
Resonance Spectroscopy (1H-MRS) has been a valuable tool to examine the neurochemical changes in the brain of SZ [4]. Metabolite
such as N-Acetyl Aspartate (NAA), Glutmate (Glu)/ Glutmin (Glx), and Choline
levels in DLPFC and other brain areas have been used to
assess the
progression of the SZ disease [5]. However, few papers reported the metabolite
changes in the animal models of SZ. In the present study, in vivo 1H-MRS were employed to investigate
alterations of metabolite in DLPFC
and VLPFC of adult monkeys with Neo-H lesions.
Methods
Adult rhesus macaques received
either sham-operations (Neo-C, n=4) or neurotoxic lesions of the hippocampus
(Neo-H, n=4) 10-15 days after birth. The MRS data were collected with a surface
coil when the animals were 5-6 years old.
Single voxel (5 × 5× 5 mm3) MRS was performed in left and
right DLPFC and VLPFC (Fig 1. A and B) with a PRESS sequence with TR/TE
=1500/30ms and CHESS water suppression.
Concentration of metabolite, including NAA, creatine and
phosphocreatine (tCr), total choline (tCho), myo-inositol (mI), and Glx, were
derived from the spectra using the LC Model software (www.s-provencher.com) and
the unsuppressed water peak was used as reference for absolute quantification.
Working memory performance was previously assessed in all animals using
the Object Self-Ordered (Obj-SO) and Session-Unique Delayed
Nonmatching-to-Sample (SU-DNMS) tasks [3].
Independent sample t test was used
to compare metabolite concentrations in selected ROIs between the two groups. Correlation between working memory scores (Obj-SO
and SU-DNMS) and neuro-metabolite (NAA, mI, tCho,
tCr, Glu and Glx) levels in the left and right DLPFC /VLPFC were investigated
using Pearson correlation coefficient. P-values less than 0.05 were
considered statistically significant in SPSS 24.0.
Results
Significant metabolite changes were
observed in the right DLPFC (Fig 1C). Compared to Neo-C, mI and tCho in right
DLPFC were significantly decreased in monkeys with Neo-H, whereas Glx were dramatically
increased (Fig.1C). No obvious metabolite changes were seen in VLPFC (Fig 1D).
In addition, right lateralization was seen both in DLPFC and VLPFC of monkeys with
Neo-H (Fig 2). There were significant correlations
between metabolite changes of tCr in DLPFC and
Obj-SO scores (Errors and total perseverative errors)
(Table 1), and between metabolite changes (i.e. mI, NAA, tCr and Glx) in
VLPFC and SU-DNMS scores (i.e. number of
trials and errors at 30sec delays) (Table 2).
Discussion and conclusion
We aimed to examine whether the
neuro-metabolites would be affected in adult monkeys with Neo-H lesions and how
changes in metabolites were correlated to cognitive performance. The present
results showed decreased NAA in Neo-H monkeys (although not significant), which
is consistent with the previous report that NAA levels decreased in the DLPFC
of patients with SZ [6]. The significant correlation between tCr in right DLPFC
and cognitive scores in Obj-SO indicated that the abnormal behavior severity is
correlated with DLPFC dysfunction caused by Neo-H lesions in infancy. The
data are consistent with prior findings of an association between tCr metabolism and cognitive function in SZ [7]. The difference between NAA changes
in left and right DLPFC and VLPFC of Neo-H monkeys are
also seen in prior study in AVH+ (auditory
verbal hallucinations) patients of SZ [8].
In conclusion, the metabolite findings in the Neo-H monkey model are consistent with previous reports in SZ patients, so it is useful to investigate the mechanism of SZ disease.
Acknowledgements
This project was funded by NIH/NIMH
grant MH0588446 (JB), the National Center for Research Resources P51RR000165,
and the office of Research Infrastructure Programs/OD P51OD011132.
References
[1] A.M. Brady, The Neonatal Ventral
Hippocampal Lesion (NVHL) Rodent Model of Schizophrenia, Curr Protoc Neurosci,
77 (2016) 9 55 51-59 55 17.
[2] X.S. Chen, C. Zhang, Y.F. Xu,
M.D. Zhang, F.Y. Lou, C. Chen, J. Tang, Neonatal ventral hippocampal lesion as
a valid model of schizophrenia: evidence from sensory gating study, Chin Med J
(Engl), 125 (2012) 2752-2754.
[3] E. Heuer, J. Bachevalier,
Neonatal hippocampal lesions in rhesus macaques alter the monitoring, but not
maintenance, of information in working memory, Behav Neurosci, 125 (2011)
859-870.
[4]
A. Schwerk, F.D. Alves, P.J. Pouwels, T. van Amelsvoort, Metabolic alterations
associated with schizophrenia: a critical evaluation of proton magnetic
resonance spectroscopy studies, J Neurochem, 128 (2014) 1-87.
[5]
J.D. Port, N. Agarwal, MR spectroscopy in schizophrenia, J Magn Reson Imaging,
34 (2011) 1251-1261.
[6] N.V. Kraguljac, M. Reid, D.
White, R. Jones, J. den Hollander, D. Lowman, A.C. Lahti, Neurometabolites in
schizophrenia and bipolar disorder - a systematic review and meta-analysis,
Psychiatry Res, 203 (2012) 111-125
[7] P.J. Allen, Creatine metabolism
and psychiatric disorders: Does creatine supplementation have therapeutic
value? Neurosci Biobehav Rev, 36 (2012) 1442-1462.
[8] M. Psomiades, M. Mondino, C.
Fonteneau, R. Bation, F. Haesebaert, M.F. Suaud-Chagny, J. Brunelin,
N-Acetyl-Aspartate in the dorsolateral prefrontal cortex in men with
schizophrenia and auditory verbal hallucinations: A 1.5 T Magnetic Resonance
Spectroscopy Study, Sci Rep, 8 (2018) 4133.